, Tracking Stock Market Picks
Enter Symbol:
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

up 120.61 %

Alexion Pharmaceuticals, Inc. (ALXN) upgraded to Outperform with price target $100 by Robert W. Baird

Posted on: Friday,  Feb 10, 2012  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 02/10/2012, when the stock price was $81.51.
Since then, Alexion Pharmaceuticals, Inc. has gained 120.61% as of 12/11/2015's recent price of $179.82.
If you would have followed this Robert W. Baird's recommendation on ALXN, you would have gained 120.61% of your investment in 1400 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2012 8:25 AM Buy
81.51 100.00
as of 12/31/2012
1 Week down  -1.72 %
1 Month down  -2.37 %
3 Months down  -18.05 %
1 YTD up  15.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2010 8:25 AM Hold
17.97 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy